Vemurafenib Plus Cobimetinib in Metastatic Melanoma
Clinical trial NCT02414750 · TERMINATED
Trial details
- NCT number
- NCT02414750
- Sponsor
- Netherlands Working Group on Immunotherapy of Oncology
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-11-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.